International Conference on Diabetes & Obesity 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Conference on Diabetes & Obesity 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
International Conference on Diabetes & Obesity 2026
The International Conference On Diabetes and Obesity is a hybrid conference taking place on September 26–27, 2026 in Barcelona, Spain, with options for participants to attend in person at Barcelona or virtually from home or work.
Theme & Conference Focus
The conference theme is “Precision Medicine in Diabetes and Obesity: From Genes to Global Health”. This focus brings together the next generation of ideas in diabetes and obesity by connecting biological and genetic understanding with broader, real-world health impacts—supporting improvements in diagnosis, treatment approaches, and population-level outcomes across global health systems.
Why This Event Matters
Diabetes-Obesity Congress 2026 is positioned as a dedicated platform for key clinical and research communities working in obesity, endocrinology, and diabetes. The conference aims to strengthen the profession through education and networking, encouraging collaboration among experts who work directly to benefit both individual patients and wider populations.
The conference also highlights the growing global relevance of diabetes and obesity, noting that diabetes affects a substantial share of hospitalized patients and that the predicted need for education and advanced management will continue to increase. By bringing together expertise and ongoing scholarly conversations, the event is designed to support future advancements in care practices and clinical excellence.
Event Format
This conference is organized as a hybrid event: participants may attend in Barcelona or join virtually online.
Venue / Accommodation (As Listed)
Hotel SB Win
Carrer de Joana Raspall, 45, 08980 Sant Feliu de L, Barcelona, Spain
Who Should Attend (Target Audience)
The conference welcomes a wide range of professionals and stakeholders connected to diabetes and obesity, including:
- Diabetologists
- Endocrinologists
- Doctors
- Assistant Professors and Professors
- Researchers
- Diabetes societies and associations
- Scientists
- Students
- CEOs
- Business delegates
Education & Accreditation
The event is listed as CPD Accredited, supporting continuing professional development for eligible attendees.
What Attendees Can Expect
The conference is designed to deliver an informative program and meaningful professional exchange. By combining education-focused sessions with opportunities to connect, the event supports participants in staying current on advances and exploring practical directions for future progress in diabetes care and obesity management.
Dates: September 26–27, 2026
Location: Barcelona, Spain
Participation: In-person in Barcelona or virtual (hybrid)
Theme: Precision Medicine in Diabetes and Obesity: From Genes to Global Health
Data sheet
International Conference on Diabetes & Obesity 2026 – Event Attendee & Buyer Profile Analysis
Event Date: September 26–27, 2026
Location: Barcelona, Spain
Event Status: Upcoming
Research Date: July 1, 2026
| Event Overview | |
| Event Name | International Conference on Diabetes & Obesity 2026 |
| Event Date | September 26–27, 2026 |
| Event Status | Upcoming |
| Venue | Hotel SB Win, Carrer de Joana Raspall, 45, 08980 Sant Feliu de L, Barcelona, Spain |
| City | Barcelona |
| State / Region | Catalonia |
| Country | Spain |
| Organizer | Mastersmind Conferences |
| Official Event Website | diabetes.mastersmindconferences.com |
| Event Type | Hybrid scientific conference and professional congress |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Education & Training |
| Audience Reach | Global, with strong Europe-based participation potential due to the Barcelona venue and hybrid format |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to medium; official website confirms the event format, dates, and venue, but not a public attendance count. |
| Main Purpose of Event | Clinical education, scientific exchange, networking, abstract presentation, and cross-disciplinary discussion on diabetes and obesity management, research, and precision medicine. |
| About the Event |
|
The International Conference on Diabetes & Obesity 2026 is a hybrid medical conference focused on diabetes, obesity, endocrinology, bariatrics, and precision medicine. The organizer positions the event as a platform for scholarly exchange and continuing education, with sessions addressing disease management, global health implications, and emerging clinical approaches.
This event is relevant to healthcare professionals, researchers, academic institutions, professional societies, and healthcare-adjacent solution providers seeking engagement with decision-makers in clinical care and medical research. It has strong value for attendee-list building in the medical and pharma ecosystem, especially for organizations targeting clinicians, hospital leaders, researchers, medical educators, and health innovation stakeholders. |
| 1. Who Attends: Buyers / Attendees | |||
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinicians and physician leaders | Hospitals, diabetes centers, endocrinology practices, bariatric clinics | Clinical evaluation, protocol adoption, referral influence | High interest in therapies, diagnostics, digital care tools, and treatment workflows |
| Researchers and academic investigators | Universities, research institutes, medical schools | Evidence generation, trial design, publication influence | Relevant for R&D, laboratory tools, study sponsors, and academic partnerships |
| Hospital administrators and service line leaders | Healthcare systems, clinics, outpatient networks | Budget oversight, technology selection, service expansion | Important for care pathway solutions, patient engagement, and operational improvement offerings |
| Pharma and biotech medical affairs | Pharmaceutical and biotechnology companies | Scientific exchange, advisory, medical education | Strong relevance for clinical education, trial recruitment, and evidence dissemination |
| Medical device and diagnostic buyers | Device manufacturers, labs, point-of-care and monitoring providers | Product assessment, innovation scouting, partnership development | Relevant for glucose monitoring, obesity screening, and care management technologies |
| Professional societies and associations | Endocrinology, diabetes, obesity, metabolic health organizations | Education, sponsorship, guideline influence | Good targets for partnerships, CME, advocacy, and event collaboration |
| Students, trainees, and early-career professionals | Medical schools, graduate programs, residency networks | Educational attendance, future buyer influence | Useful for academic products, training resources, and digital learning platforms |
| 2. Event Location and Attendee Geographic Origin | |||
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Barcelona metro area and nearby Catalonia healthcare institutions | High | In-person attendance is likely strongest from local hospitals, universities, and clinical networks. |
| Host region | Catalonia and broader Spain | High | Strong domestic reach for Spanish-speaking clinicians and researchers. |
| Nearby business hubs | Madrid, Valencia, Zaragoza, Bilbao, southern France, Milan, Paris | Medium to high | Hybrid format broadens reach beyond immediate travel radius. |
| National reach | Nationwide Spain-based medical professionals and institutions | High | Relevant for attendee list building across hospitals, universities, and specialty clinics. |
| International reach | Europe, Middle East, Asia-Pacific, North America, and global research communities | Medium | The conference branding and hybrid access support cross-border participation. |
| 3. Audience Reach | ||
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The conference is positioned as an international medical congress with a hybrid format, making it relevant to global clinical, academic, and industry audiences. |
| 4. Sample Buyer Companies and Websites | |||||
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Novo Nordisk | Pharma / metabolic health | Major diabetes and obesity treatment stakeholder with strong interest in scientific congresses. | novonordisk.com | Medical Affairs Director, Brand Director, Clinical Development Lead | Strong Market Fit, Attendance Not Confirmed |
| Eli Lilly and Company | Pharma / diabetes care | Relevant for obesity and diabetes research, education, and market access teams. | lilly.com | Medical Director, Market Access Director, Clinical Science Lead | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Pharma | Global healthcare company with interest in endocrinology, metabolic disease, and medical education. | sanofi.com | Medical Affairs Lead, HEOR Manager, Scientific Communications Manager | Strong Market Fit, Attendance Not Confirmed |
| Roche Diabetes Care | Diagnostics / medical devices | Monitoring, diagnostics, and digital diabetes management are highly aligned with the conference theme. | roche.com | Business Development Manager, Product Manager, Clinical Evidence Manager | Strong Market Fit, Attendance Not Confirmed |
| Abbott | Medical devices / diagnostics | Relevant for glucose monitoring and connected health solutions. | abbott.com | Innovation Manager, Marketing Director, Clinical Affairs Director | Strong Market Fit, Attendance Not Confirmed |
| Medtronic | Medical devices | Relevant for diabetes technology, device education, and clinical adoption teams. | medtronic.com | Product Marketing Director, Clinical Education Lead, Regional Sales Director | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson MedTech | Medical devices | Potential interest in surgical, metabolic, and care pathway solutions tied to obesity treatment. | jnj.com | Strategic Partnerships Director, Business Development Manager, Clinical Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| Boehringer Ingelheim | Pharma | Major cardiometabolic player with relevance for diabetes-adjacent clinical audiences. | boehringer-ingelheim.com | Medical Science Liaison, Medical Affairs Director, Evidence Generation Lead | Strong Market Fit, Attendance Not Confirmed |
| University Hospital Network | Hospital / healthcare system | Representative buyer category for clinical programs, education, and care innovations. | Example: ehda.es | Chief Medical Officer, Endocrinology Department Head, Procurement Director | Strong Market Fit, Attendance Not Confirmed |
| Federation / Diabetes Association | Association / nonprofit | Educational and advocacy organization with strong conference alignment. | idf.org | Executive Director, Program Director, Partnership Manager | Strong Market Fit, Attendance Not Confirmed |
| 5. Job Profiles, Industries and Event Type | ||||
| Priority Job Profiles | ||||
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer | Clinical leadership | C-level | Influences care priorities, partnerships, and adoption of clinical solutions. |
| 2 | Endocrinology Department Head | Clinical operations | Director / Head | Primary decision-maker for clinical workflows, therapies, and care pathways. |
| 3 | Medical Affairs Director | Medical affairs | Director / VP | Key for scientific engagement, education, and congress participation. |
| 4 | Clinical Development Lead | R&D / clinical development | Manager / Director | Relevant for trials, evidence generation, and investigator engagement. |
| 5 | Research Principal Investigator | Academia / research | Professor / Senior researcher | Drives publications, collaborations, and grant-funded studies. |
| 6 | Clinical Affairs Manager | Medical devices / diagnostics | Manager | Supports product validation, physician education, and adoption. |
| 7 | Hospital Procurement Director | Procurement | Director | Important for purchasing devices, software, and clinical services. |
| 8 | University Dean / Program Director | Education | Dean / Director | Can influence attendance, speaking, and academic partnership opportunities. |
| Recommended Apollo Industries | |||
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base includes hospitals and care providers. | Clinical decision-makers, service-line leaders, hospital administrators |
| 2 | Pharmaceuticals | Diabetes and obesity therapeutics are central to the event theme. | Medical affairs, market access, clinical development |
| 3 | Medical Devices | Relevant for monitoring, diagnostics, and treatment support technologies. | Product leaders, clinical affairs, commercial directors |
| 4 | Biotechnology | Research-heavy event with translational science relevance. | R&D, translational medicine, scientific partnerships |
| 5 | Biotechnology Research | Useful for lab-based innovation and discovery. | Researchers, lab managers, science leads |
| 6 | Research | Academic and clinical research participation is prominent. | Principal investigators, study sponsors, research directors |
| 7 | Higher Education | Conference attracts academics, professors, and trainees. | Deans, department chairs, faculty sponsors |
| 8 | Medical Practice | Specialty clinics and physician groups are core attendees. | Practice owners, medical directors, physicians |
| 9 | Health, Wellness & Fitness | Obesity management intersects with lifestyle and wellness programs. | Program managers, wellness directors, patient engagement leads |
| 10 | Information Technology & Services | Digital health, remote monitoring, and patient data workflows are relevant. | Digital health leaders, CIO/CTO teams, product teams |
| 11 | Government Administration | Public health, reimbursement, and hospital systems may attend or partner. | Public health officials, procurement, program directors |
| 12 | Biotechnology / Medical Research | Strong overlap with precision medicine and translational health themes. | Scientific leadership, partnerships, innovation teams |
| 6. Estimated Attendance | ||||
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Organizer website does not publish a verified attendance count | Use as a lead-generation event even without a public count |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | No public exhibitor directory located in the provided official text | Likely more conference-led than expo-led |
| Buyer count | Not publicly confirmed | Confirmed unavailable | No buyer list published | Buyer intent is inferred from attendee profile |
| Speaker count | Not publicly confirmed | Confirmed unavailable | Speaker page referenced, but no speaker count was provided in the supplied official text | Speaker roster should be checked directly on the official speakers page |
| Sponsor count | Not publicly confirmed | Confirmed unavailable | No sponsor list provided in the supplied content | Potential sponsor categories include pharma, devices, diagnostics, and education providers |
| Historical attendance | Not verified here | Historical / prior-year evidence not supplied | No prior-year official attendance figures were provided in the source excerpt | Avoid quoting attendance numbers without organizer confirmation |
| 7. Key Focus Areas and Buyer Engagement | |||
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical education | Updated treatment knowledge, guidelines, and best practices | CME support, workshops, speaker sessions | Medical education services, content platforms |
| Precision medicine | Personalized treatment and biomarker-driven care | Scientific sessions and research collaboration | Genomics, diagnostics, data analytics |
| Diabetes monitoring | Continuous glucose monitoring, remote care, adherence | Device demos, clinical evidence conversations | Monitoring devices, software, connected health tools |
| Obesity treatment | Therapies, bariatric pathways, multidisciplinary care | Clinical exchange and treatment planning | Pharma, surgical support, patient programs |
| Research and trials | Investigator recruitment, study design, publication support | Abstracts, poster sessions, investigator meetings | Clinical trial services, R&D partnerships |
| Digital health | Data capture, telehealth, patient engagement | Product demos and integration discussions | Health IT, dashboards, remote monitoring platforms |
| Lead Quality Assessment | ||
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event attracts clinicians, researchers, and healthcare stakeholders directly involved in diabetes and obesity. |
| Decision-maker availability | High | Department heads, medical directors, academics, and medical affairs professionals are likely attendees. |
| Data collection potential | Medium | Useful for attendee profiling, though public lists are limited in the supplied source text. |
| Apollo targeting potential | High | Strong alignment with hospital, pharma, devices, research, and higher education segments. |
| Geographic targeting potential | High | Barcelona, Spain, Catalonia, and broader European healthcare organizations are logical targeting zones. |
| Best outreach approach | High-touch, topic-led | Lead with precision medicine, diabetes care, obesity treatment, and clinical education value propositions. |
| Overall lead quality | High | Strong fit for life sciences, medical devices, digital health, and research outreach. |
| Best use case | Attendee list sales, sponsorship prospecting, and healthcare account targeting | Most useful for B2B outreach to clinical, research, and commercial stakeholders. |
| Limitations / risks | Moderate | No public attendee list or attendance count was confirmed in the supplied official text; buyer intent must be inferred from the agenda and audience description. |
| Apollo.io Targeting Recommendation | ||
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Medical Devices; Biotechnology; Research; Higher Education; Information Technology & Services; Government Administration; Health, Wellness & Fitness | Capture the core attendee and buyer ecosystem. |
| Departments | Medical Affairs, Clinical Development, Research, Procurement, Business Development, Partnerships, Product, Marketing, Innovation, Operations | Identify both clinical attendees and commercial decision-makers. |
| Seniority | Manager, Director, VP, CXO, Professor, Department Head, Principal Investigator | Prioritize influential attendees and budget holders. |
| Job titles | Chief Medical Officer, Medical Affairs Director, Clinical Development Lead, Endocrinology Head, Research Director, Professor, Clinical Affairs Manager, Product Manager, Hospital Procurement Director, Program Director | Focus outreach on likely buyers, evaluators, and conference participants. |
| Geography | Spain; Catalonia; Barcelona; broader Europe; United Kingdom; France; Italy; Germany; Netherlands; selected global hubs | Localize outreach while preserving international reach. |
| Employee size | 50–200; 201–500; 501–1,000; 1,001–5,000; 5,000+ | Cover specialty clinics, hospitals, research bodies, and multinationals. |
| Keywords | diabetes, obesity, endocrinology, bariatric, metabolic health, precision medicine, glucose monitoring, medical affairs, clinical research, endocrinology, patient engagement | Improve relevance and exclude unrelated healthcare accounts. |
| Company type | Private, public, nonprofit, academic, government-linked healthcare organizations | Capture the full attendee ecosystem. |
| Revenue range | Where relevant, prioritize mid-market to enterprise healthcare and life sciences organizations | Target organizations with buying power and event sponsorship potential. |
Suggested Apollo Search Logic:
(diabetes OR obesity OR endocrinology OR bariatric OR metabolic health OR precision medicine) AND (Hospital & Health Care OR Pharmaceuticals OR Medical Devices OR Biotechnology OR Research OR Higher Education) AND (Director OR VP OR Head OR Manager OR CMO OR Professor OR Principal Investigator)
| Best Buyer Targets for Client | |||||||
|
Client Fit Review Required Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event. |
| Sources & Verification Notes | |||
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Official Event Website | Primary source | Event name, hybrid format, dates, venue, city, country, organizer branding, and target audience description | High |
| Official Home Page Content Provided by User | Primary source excerpt | Confirmed Barcelona venue details, schedule window, and attendee positioning for diabetologists, endocrinologists, researchers, and business delegates | High |
| Venue / Accommodation Details on Official Site | Primary source excerpt | Hotel SB Win address in Sant Feliu de L, Barcelona, Spain | High |
| Organizer Website Navigation References | Primary source excerpt | Presence of brochure, speakers, sessions, abstract, register, and venue information pages | Medium to high |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Conference on Diabetes & Obesity 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds